LENZ Therapeutics and JIXING Announce an Exclusive Greater China License Agreement; RTW to Invest in…
– JIXING to lead development and commercialization of LNZ100 and LNZ101 in Greater China –
– LENZ to receive up to $110 million in upfront and…